| Andrew Kolker, MD | |
|
2150 Pennsylvania Ave Nw, Suite 2a, Washington, DC 20037-3201 | |
| (202) 741-2800 | |
| Not Available |
| Full Name | Andrew Kolker |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 9 Years |
| Location | 2150 Pennsylvania Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184912347 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MTL000508 (District Of Columbia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Doctors Of Washington Pc | 5799758595 | 13 |
| Paul Shannon Cunningham | 2264466143 | 3 |
News Archive
Daniel H. Solomon, M.D., M.P.H., from Brigham and Women's Hospital, Boston, and Jerry Avorn, M.D., of Harvard University School of Medicine, write in the January 24 issue of Archives of Internal Medicine that the withdrawal of rofecoxib (Vioxx) from the market in September 2004 by its manufacturer, Merck & Co., "raises many questions concerning drug policy, scientific evidence, and treatment alternatives.
ITL Group has successfully passed its latest audit conducted by the US Food and Drug Administration (FDA) at their facility in Ashford, Kent with no observations found.
Closing of local automotive assembly plants may lead to increases in deaths from opioid overdose, according to a study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and the Massachusetts General Hospital.
BTG plc, a global specialist healthcare company, today announced it has received 510k clearance from the US Food and Drug Administration for LC Bead LUMI, the first commercially available radiopaque embolic bead for the embolization of hypervascular tumors and arteriovenous malformations (AVMs).
Differences in lung physiology and immune function in children could be why they are more often spared from severe illness associated with COVID-19 than adults, according to pediatric and adult physicians at The University of Texas Health Science Center at Houston and Baylor College of Medicine, who teamed up to investigate the disparity.
› Verified 7 days ago
| Entity Name | Eye Doctors Of Washington Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952438202 PECOS PAC ID: 5799758595 Enrollment ID: O20040819000125 |
News Archive
Daniel H. Solomon, M.D., M.P.H., from Brigham and Women's Hospital, Boston, and Jerry Avorn, M.D., of Harvard University School of Medicine, write in the January 24 issue of Archives of Internal Medicine that the withdrawal of rofecoxib (Vioxx) from the market in September 2004 by its manufacturer, Merck & Co., "raises many questions concerning drug policy, scientific evidence, and treatment alternatives.
ITL Group has successfully passed its latest audit conducted by the US Food and Drug Administration (FDA) at their facility in Ashford, Kent with no observations found.
Closing of local automotive assembly plants may lead to increases in deaths from opioid overdose, according to a study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and the Massachusetts General Hospital.
BTG plc, a global specialist healthcare company, today announced it has received 510k clearance from the US Food and Drug Administration for LC Bead LUMI, the first commercially available radiopaque embolic bead for the embolization of hypervascular tumors and arteriovenous malformations (AVMs).
Differences in lung physiology and immune function in children could be why they are more often spared from severe illness associated with COVID-19 than adults, according to pediatric and adult physicians at The University of Texas Health Science Center at Houston and Baylor College of Medicine, who teamed up to investigate the disparity.
› Verified 7 days ago
| Entity Name | Paul Shannon Cunningham |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609942945 PECOS PAC ID: 2264466143 Enrollment ID: O20050920001124 |
News Archive
Daniel H. Solomon, M.D., M.P.H., from Brigham and Women's Hospital, Boston, and Jerry Avorn, M.D., of Harvard University School of Medicine, write in the January 24 issue of Archives of Internal Medicine that the withdrawal of rofecoxib (Vioxx) from the market in September 2004 by its manufacturer, Merck & Co., "raises many questions concerning drug policy, scientific evidence, and treatment alternatives.
ITL Group has successfully passed its latest audit conducted by the US Food and Drug Administration (FDA) at their facility in Ashford, Kent with no observations found.
Closing of local automotive assembly plants may lead to increases in deaths from opioid overdose, according to a study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and the Massachusetts General Hospital.
BTG plc, a global specialist healthcare company, today announced it has received 510k clearance from the US Food and Drug Administration for LC Bead LUMI, the first commercially available radiopaque embolic bead for the embolization of hypervascular tumors and arteriovenous malformations (AVMs).
Differences in lung physiology and immune function in children could be why they are more often spared from severe illness associated with COVID-19 than adults, according to pediatric and adult physicians at The University of Texas Health Science Center at Houston and Baylor College of Medicine, who teamed up to investigate the disparity.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Kolker, MD 1010 25th St Nw, Apartment 204, Washington, DC 20037-1658 Ph: (410) 627-9627 | Andrew Kolker, MD 2150 Pennsylvania Ave Nw, Suite 2a, Washington, DC 20037-3201 Ph: (202) 741-2800 |
News Archive
Daniel H. Solomon, M.D., M.P.H., from Brigham and Women's Hospital, Boston, and Jerry Avorn, M.D., of Harvard University School of Medicine, write in the January 24 issue of Archives of Internal Medicine that the withdrawal of rofecoxib (Vioxx) from the market in September 2004 by its manufacturer, Merck & Co., "raises many questions concerning drug policy, scientific evidence, and treatment alternatives.
ITL Group has successfully passed its latest audit conducted by the US Food and Drug Administration (FDA) at their facility in Ashford, Kent with no observations found.
Closing of local automotive assembly plants may lead to increases in deaths from opioid overdose, according to a study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and the Massachusetts General Hospital.
BTG plc, a global specialist healthcare company, today announced it has received 510k clearance from the US Food and Drug Administration for LC Bead LUMI, the first commercially available radiopaque embolic bead for the embolization of hypervascular tumors and arteriovenous malformations (AVMs).
Differences in lung physiology and immune function in children could be why they are more often spared from severe illness associated with COVID-19 than adults, according to pediatric and adult physicians at The University of Texas Health Science Center at Houston and Baylor College of Medicine, who teamed up to investigate the disparity.
› Verified 7 days ago
Dr. Saima M Qureshi, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2041 Georgia Ave Nw, Washington, DC 20060 Phone: 202-865-6100 | |
Melanie J Buttross, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4910 Massachusetts Ave Nw, Ste 21, Washington, DC 20016 Phone: 202-686-6700 Fax: 202-537-1442 | |
Dr. Bilal Khan Yousufzai, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Dept Of Ophthalmology, Washington, DC 20010 Phone: 202-877-5658 Fax: 202-877-7743 | |
Dr. Marc Jay Holzman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2021 K St Nw, Suite 416, Washington, DC 20006 Phone: 202-296-1333 Fax: 202-296-9357 | |
Dr. Bethany A Karwoski, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Kelly Hutcheson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-884-3015 | |
Dr. Reginald Dacosta Barnes Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2112 F St Nw Ste 802, Washington, DC 20037 Phone: 202-331-1757 Fax: 202-331-1757 |